Home/Filings/4/0001293941-05-000043
4//SEC Filing

EYETECH PHARMACEUTICALS INC 4

Accession 0001293941-05-000043

CIK 0001115285operating

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 4:14 PM ET

Size

7.2 KB

Accession

0001293941-05-000043

Insider Transaction Report

Form 4
Period: 2005-06-28
ADAMIS ANTHONY P
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2005-06-28$0.01/sh+92,500$925120,615 total
Holdings
  • Common Stock

    (indirect: by Daughter)
    6,280
Footnotes (2)
  • [F1]These shares are held in a trust for the benefit of the reporting person's daughter. The reporting person's brother-in law is the trustee of the trust. The reporting person disclaims benefical ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for puposes of Section 16 or for any other purpose.
  • [F2]These shares are held in a trust for the benefit of the reporting person's son. The reporting person's brother -in-law is the trustee of the trust. The reporting person disclaims beneficial ownership of these securiites, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for Section 16 or for any other pupose.

Issuer

EYETECH PHARMACEUTICALS INC

CIK 0001115285

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001115285

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:14 PM ET
Size
7.2 KB